Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation

Journal of Viral Hepatitis

Volumn 16, Issue 10, 2009, Pages 732-737

  Mello, I M V G C ^a   Thumann, C ^b   Schvoerer, E ^c   Soulier, E ^b   Pinho, J R R ^d   Silvestre, D A M M ^d   Queiroz, A T L ^d   Wolf, P ^b,c   Baumert, T F ^b,c   Keller, F S ^c   Pereira, C A ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b INSERM   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

HCV; Hepatitis; Liver transplantation; Ns3

Indexed keywords

EPITOPE; NONSTRUCTURAL PROTEIN 3; ZINC;

AMINO ACID SEQUENCE; ARTICLE; CATALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENETIC DISTANCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECURRENT DISEASE; SEQUENCE ANALYSIS; SUBSTITUTION REACTION; VIRUS ISOLATION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; EPITOPES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER TRANSPLANTATION; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PHYLOGENY; POINT MUTATION; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; VIRAL NONSTRUCTURAL PROTEINS;

EID: 70349257696     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2009.01125.x     Document Type: Article

References (32)

1. Farci P., Shimoda A, Coiana A et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000 288 : 339 344.
2. von Hahn T, Yoon JC, Alter H, Rice CM, Rehermann B et al. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 2007 132 : 667 678.
3. Hanada K, Tanaka Y, Mizokami M, Gojobori T, Alter HJ. A reduction in selective immune pressure during the course of chronic hepatitis C correlates with diminished biochemical evidence of hepatic inflammation. Virology 2007 361 : 27 33.
4. Imbert I, Dimitrova M, Wolf M, Schuster C. Réplication du virus de l'hépatite C: systèmes d'étude, avantages et limites. Virologie 2004 8 : 281 295.
5. Suzich JA, Tamura JK, Palmer-Hill F, Warrener P, Grakoui A et al. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J Virol 1993 67 : 6152 6158.
6. Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A 1991 88 : 5547 5551.
7. Machida K, Cheng KT, Lai CK, Jeng KS, Sung VM et al. Hepatitis C virus triggers mitochondrial permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation. J Virol 2006 80 : 7199 7207.
8. Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 1995 69 : 3893 3896.
9. Zemel R, Gerechet S, Greif H, Bachmatove L, Birk Y et al. Cell transformation induced by hepatitis C virus NS3 serine protease. J Viral Hepat 2001 8 : 96 102.
10. Cheng PL, Chang MH, Chao CH, Lee YH. Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation. Oncogene 2004 23 : 7821 7838.
11. Foy E, Li K, Wang C, Sumpter Jr. R, Ikeda M et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 2003 300 : 1145 1148.
12. Foy E, Li K, Sumpter Jr. R, Loo YM, Johnson CL et al. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc Natl Acad Sci U S A 2005 102 : 2986 2991.
13. Breiman A, Grandvaux N, Lin R, Ottone C, Akira S et al. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon. J Virol 2005 79 : 3969 3978.
14. Deng L, Nagano-Fujii M, Tanaka M, Nomura-Takigawa Y, Ikeda M et al. NS3 protein of Hepatitis C virus associates with the tumour suppressor p53 and inhibits its function in an NS3 sequence-dependent manner. J Gen Virol 2006 87 : 1703 1713.
15. Lai CK, Jeng KS, Machida K, Cheng YS, Lai MM. Hepatitis C virus NS3/4A protein interacts with ATM, impairs DNA repair and enhances sensitivity to ionizing radiation. Virology 2008 370 : 295 309.
16. Gimenez-Barcons M, Franco S, Suarez Y, Forns X, Ampurdanes S et al. High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis. Hepatology 2001 34 : 158 167.
17. Ogata S, Florese RH, Nagano-Fujii M, Hidajat R, Deng L et al. Identification of hepatitis C virus (HCV) subtype 1b strains that are highly, or only weakly, associated with hepatocellular carcinoma on the basis of the secondary structure of an amino-terminal portion of the HCV NS3 protein. J Clin Microbiol 2003 41 : 2835 2841.
18. Cubero M, Esteban JI, Otero T, Sauleda S, Bes M et al. Naturally occurring NS3-protease-inhibitor resistant mutant A156T in the liver of an untreated chronic hepatitis C patient. Virology 2008 370 : 237 245.
19. Ito K, Shiraki K, Funatsuki K, Ishiko H, Sugimoto K et al. Identification of novel hepatitis C virus-specific cytotoxic T lymphocyte epiotpe in NS3 region. Hepatol Res 2006 36 : 294 300.
20. Simmonds P. Genetic diversity and evolution of hepatitis C virus - 15 years on. J Gen Virol 2004 85 : 3173 3188.
21. Schvoerer E, Soulier E, Royer C, Renaudin AC, Thumann C et al. Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease. J Infect Dis 2007 196 : 528 536.
22. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007 24 : 1596 1599.
23. Swofford DL. PAUP* Phylogenetic Analysis Using Parsimony (*and Other Methods). Version 4 ed. Sunderland, MA : Sinauer Associates, 2002.
24. Posada D, Crandall KA. MODELTEST: testing the model of DNA substitution. Bioinformatics 1998 14 : 817 818.
25. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987 4 : 406 425.
26. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985 39 : 783 791.
27. Zharkikh A, Li WH. Estimation of confidence in phylogeny: the complete-and-partial bootstrap technique. Mol Phylogenet Evol 1995 4 : 44 63.
28. Garnier J, Gibrat JF, Robson B. GOR method for predicting protein secondary structure from amino acid sequence. Methods Enzymol 1996 266 : 540 553.
29. McCaughan GW, Zekry A. Mechanisms of HCV reinfection and allograft damage after liver transplantation. J Hepatol 2004 40 : 368 374.
30. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001 358 : 958 965. (Pubitemid 32913521)
31. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002 347 : 975 982.
32. Mathy JE, Ma S, Compton T, Lin K. Combinations of a cyclophilin inhibitor NIM811 with HCV NS3-4A protease or NS5B polymerase inhibitors enhance antiviral activity and suppress the emergence of resistance. Antimicrob Agents Chemother 2008 52 : 3267 3275.